← Open Payments lookup

MIRIAM ZIMELA: Open Payments

NPI 1265806574 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$484 in 20 payments from 6 companies in 2025. Trend: 2023 $89 · 2024 $37 · 2025 $484

Food & beverage: $484
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.8$238
Supernus Pharmaceuticals, Inc.5$98
Alkermes, Inc.4$79
Neurocrine BioSciences, Inc.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$25
Axsome Therapeutics, Inc.1$19

Products named: COBENFY, Qelbree, ARISTADA, INGREZZA, CAPLYTA, Auvelity.

Industry payments across MD — which companies pay providers there.